LTRAs urged for poorly controlled asthma

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

A leucotriene receptor antagonist should be offered before a combination inhaler in patients with poorly controlled asthma, draft guidance from the National Institute for Health and Care Excellence (NICE) recommends.1

The generic leucotriene receptor antagonist montelukast costs just 7p (€0.08; $...